Indeed, studies in LRRK2 models suggest that LRRK2 mutation alone is not sufficient to cause DA neuron loss, questioning the face validity of LRRK2 rodents as models of the clinical phase of PD. This evidence concerns the gene LRRK2 and Parkinson disease.